Physician profile
Edward L Patterson
NPI 1841261682
$917.76
in general payments reported to CMS, 2019-2025
13 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.79 · 2020: $84.64 · 2021: $75.80 · 2022: $153 · 2023: $172 · 2024: $212 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.43 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $253.65 | 2019-2025 | Bexsero, Rotarix, Penmenvy |
| Cranial Technologies, INC | $176.59 | 2021-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $127.39 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $112.88 | 2021-2024 | |
| Seqirus USA INC | $70.92 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Pfizer INC. | $65.11 | 2022-2024 | |
| Redhill Biopharma INC. | $24.76 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.14 | 2024 | Flumist Quadrivalent |
| Phadia US INC. | $18.33 | 2020 | |
| Mirum Pharmaceuticals, INC. | $16.29 | 2023 | Livmarli |
| Lnhc, INC | $15.58 | 2025 | Zelsuvmi |
| Acadia Pharmaceuticals INC | $15.33 | 2025 | Daybue |
| Travere Therapeutics, INC. | $0.79 | 2023 | Cholbam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.